Advertisement

Investigational New Drugs

, Volume 32, Issue 2, pp 388–388 | Cite as

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

  • Yu Sunakawa
  • Junji Furuse
  • Takuji Okusaka
  • Masafumi Ikeda
  • Fumio Nagashima
  • Hideki Ueno
  • Shuichi Mitsunaga
  • Kensei Hashizume
  • Yuichiro Ito
  • Yasutsuna Sasaki
Erratum
  • 699 Downloads

Erratum to: Invest New Drugs

DOI 10.1007/s10637-013-9953-8

Following online publication of this article, some factual and typographical errors have been identified; the correct details are as follows: In the results section (safety subsection), the rate of leukopenia was 27 % (not 33 %), and four patients experienced grade 3 lymphopenia (not five patients). In the efficacy subsection, the duration of response should be 10.4 months (not 10.5 months). In Table 2, the rate of any-grade proteinuria should be 80 % (not 8 %). In Table 4, the AUC0–24 for the M5 metabolite should be 380.0 (164.2) μg.h/L (not 380.5/164.2(112.0)).

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Yu Sunakawa
    • 1
  • Junji Furuse
    • 2
  • Takuji Okusaka
    • 3
  • Masafumi Ikeda
    • 4
  • Fumio Nagashima
    • 2
  • Hideki Ueno
    • 3
  • Shuichi Mitsunaga
    • 4
  • Kensei Hashizume
    • 5
  • Yuichiro Ito
    • 6
  • Yasutsuna Sasaki
    • 7
  1. 1.International Medical Center-Comprehensive Cancer CenterSaitama Medical UniversityHidakaJapan
  2. 2.Department of Medical OncologyKyorin University, School of MedicineTokyoJapan
  3. 3.Hepatobiliary and Pancreatic Oncology DivisionNational Cancer Center HospitalTokyoJapan
  4. 4.Division of Hepatobiliary and Pancreatic OncologyNational Cancer Center Hospital EastChibaJapan
  5. 5.Global Drug Discovery, Clinical PharmacologyBayer Yakuhin, Ltd.OsakaJapan
  6. 6.Product Development DepartmentBayer Yakuhin, Ltd.OsakaJapan
  7. 7.Division of Medical Oncology, Department of MedicineShowa University School of MedicineTokyoJapan

Personalised recommendations